CRDF FY 2021 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$139M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$359,000-1.9% YoY

Gross Profit

$359,000100.0% margin

Operating Income

-$29M-8037.6% margin

Net Income

-$28M-7880.5% margin

EPS (Diluted)

$-0.73

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$150M

Total Liabilities

$9M

Stockholders' Equity

$140M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$359,000	$366,000	-1.9%
Gross Profit	$359,000	$366,000	-1.9%
Operating Income	-$29M	-$19M	-51.2%
Net Income	-$28M	-$19M	-46.5%